Jonathan Savidge
JS
Jonathan Savidge
CEO
Rate
About
Jonathan Savidge is a scientist by training with 25 years of experience in the biotech/pharma industry, focusing on strategic partnerships for novel therapeutics. He has served as CEO for two companies, Syndesi Therapeutics and Kynos Therapeutics, both of which had significant M&A exits. He is currently the Board Chair at NRG Therapeutics and advises biotech companies and investors in the CNS and pain therapeutic areas.
Frequently asked
Who is Jonathan Savidge?
Jonathan Savidge is a scientist by training with 25 years of experience in the biotech/pharma industry, focusing on strategic partnerships for novel therapeutics. He has served as CEO for two companies, Syndesi Therapeutics and Kynos Therapeutics, both of which had significant M&A exits. He is currently the Board Chair at NRG Therapeutics and advises biotech companies and investors in the CNS and…
What is Jonathan Savidge's current role?
Jonathan Savidge is currently CEO.
Comments
No comments yet. Be the first to share your take.
Profile
About Jonathan Savidge
Jonathan Savidge is CEO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.